ArcherDX Launches Certified Service Provider Program, Pathgroup First Approved Provider

BOULDER, Colo. & NASHVILLE, Tenn.--(BUSINESS WIRE)--ArcherDX, the leading provider of NGS-based fusion detection assays and software, has certified PathGroup, a leading reference laboratory and CRO, as the first Certified Service Provider (CSP) of their new Archer™ CSP Program.

Based in Nashville, TN, PathGroup is one of the largest physician-owned pathology groups in the United States with over 80 pathologists and a leader in the field of anatomic, clinical and molecular pathology.

Building off of the success of their FusionPlex™ NGS assays, ArcherDX recently launched the Archer Certified Service Provider Program, enabling elite molecular oncology testing laboratories to offer Archer assays as part of their service offering.

Dr. James Prescott, Director of Molecular Diagnostics at PathGroup, stated, “There is a huge demand for RNA-based gene fusion detection, and Archer’s FusionPlex assays are by far the best option on the market. Being part of Archer’s CSP program will allow PathGroup to provide services for BioPharma customers, which will be of great interest for clinical research groups investigating gene fusions.”

In addition to their role as a reference laboratory, PathGroup has become increasingly involved with clinical trials in recent years. Led by a scientific team of board-certified pathologists who are recognized experts in their field of anatomic, molecular pathology and bioinformatics, PathGroup works with leading BioPharma and CRO partners in developing solutions for improved clinical trial outcomes.

Jason Myers, PhD, CEO at ArcherDX, added, “PathGroup has long been recognized as a leading molecular pathology laboratory, but they are also working with a number of groups to support clinical trials in oncology. Given the large number of targeted inhibitors in development, we are pleased that PathGroup will be able to offer Archer assays among their services to BioPharma customers.”

About ArcherDX

ArcherDX addresses the bottlenecks associated with using NGS in translational research by offering a robust platform for targeted sequencing applications. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry and easy-to-use, lyophilized reagents, Archer NGS assays generate highly enriched sequencing libraries to detect gene fusions, point mutations, CNVs and RNA abundance. Complemented by the Archer suite of bioinformatics software, ArcherDX technology dramatically enhances complex mutation identification and discovery.

ArcherDX is headquartered in Boulder, Colo., and maintains manufacturing operations in Beverly, Mass.

Archer FusionPlex NGS Assays

Archer offers a wide range of RNA-based FusionPlex panels targeting important, cancer-related fusion events from low-input FFPE samples. The system leverages the proprietary Anchored Multiplex PCR (AMP™) to selectively amplify cDNAs of specific genes of interest in a sample along with any fusion partners, known or unknown. FusionPlex assays are just part of Archer’s targeted NGS mutation detection workflow that includes the PreSeq RNA QC Assay, completely lyophilized kits for library preparation, and a powerful bioinformatics suite.

Archer Certified Service Provider Program

The Archer Certified Service Provider Program is a partnership forged between Archer and participating laboratories. These collaborative efforts are the beginning of an ongoing relationship that continues far past the certification process. Benefits of the CSP program to providers are increased referrals and endorsements, early access to new Archer technologies and co-branding with Archer, including listing on Archer’s CSP list of providers.

Note: Archer kits and analysis software are for research use only and not for use in diagnostic procedures.

http://archerdx.com

About PathGroup

Founded in 1965, PathGroup has evolved into a premier provider of anatomic, clinical and molecular pathology services. Privately held and physician centric, PathGroup works seamlessly with customers to provide superior diagnostic services - a vital link in the cycle of patient relationships. PathGroup uses the latest in proprietary and industry standard technology to deliver fast, accurate results. The company provides clients with the highest quality of services available, consistently exceeding the expectations of physicians, employees, payers and most importantly, patients. One Lab; Total Service. For more information, visit www.pathgroup.com.

PathGroup BioPharma Services

With our diversified molecular pathology portfolio, sophisticated bioinformatics solutions and access to an extensive network of community based clinicians, PathGroup is uniquely positioned to support clinical trial programs. For more information, email: BioPharma@pathgroup.com